Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,092 | 178 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $531.36 | 22 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $373.62 | 17 | $0 (2022) |
| Novo Nordisk Inc | $297.50 | 19 | $0 (2022) |
| PFIZER INC. | $280.99 | 20 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $241.72 | 14 | $0 (2022) |
| Lilly USA, LLC | $226.06 | 15 | $0 (2022) |
| GlaxoSmithKline, LLC. | $225.22 | 14 | $0 (2022) |
| Takeda Pharmaceuticals U.S.A., Inc. | $151.89 | 10 | $0 (2022) |
| Amgen Inc. | $117.88 | 7 | $0 (2022) |
| Amarin Pharma Inc. | $80.76 | 4 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $12.91 | 1 | Merck Sharp & Dohme LLC ($12.91) |
| 2022 | $832.20 | 45 | ABBVIE INC. ($279.30) |
| 2021 | $2,247 | 132 | AstraZeneca Pharmaceuticals LP ($344.07) |
All Payment Transactions
178 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/19/2023 | Merck Sharp & Dohme LLC | BELSOMRA (Drug) | Food and Beverage | In-kind items and services | $12.91 | General |
| Category: NEUROSCIENCE | ||||||
| 12/11/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $25.59 | General |
| Category: NEUROSCIENCE | ||||||
| 09/20/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: NEUROSCIENCE | ||||||
| 09/08/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: RESPIRATORY | ||||||
| 08/02/2022 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.53 | General |
| Category: Diabetes | ||||||
| 07/11/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $29.63 | General |
| Category: NEUROSCIENCE | ||||||
| 07/06/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $29.56 | General |
| Category: NEUROSCIENCE | ||||||
| 06/30/2022 | Inogen, Inc. | InogenOne (Device) | Food and Beverage | Cash or cash equivalent | $1.27 | General |
| Category: Oxygen Concentrator | ||||||
| 06/29/2022 | Inogen, Inc. | InogenOne (Device) | Food and Beverage | Cash or cash equivalent | $7.26 | General |
| Category: Oxygen Concentrator | ||||||
| 06/28/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $12.84 | General |
| Category: Diabetes | ||||||
| 06/20/2022 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $22.49 | General |
| Category: Diabetes | ||||||
| 06/06/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.38 | General |
| Category: RESPIRATORY | ||||||
| 05/31/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $28.28 | General |
| Category: NEUROSCIENCE | ||||||
| 05/27/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.49 | General |
| Category: Cardio-renal | ||||||
| 05/26/2022 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.58 | General |
| Category: Respiratory | ||||||
| 05/24/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.68 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/19/2022 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: Inflammation | ||||||
| 05/17/2022 | Mannkind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $24.05 | General |
| Category: DIABETES MEDICINE | ||||||
| 05/14/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.10 | General |
| Category: Diabetes | ||||||
| 05/13/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $13.26 | General |
| Category: PRIMARY CARE | ||||||
| 05/11/2022 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $11.66 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/10/2022 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $16.47 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/03/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $27.99 | General |
| Category: NEUROSCIENCE | ||||||
| 04/14/2022 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.46 | General |
| Category: Inflammation | ||||||
| 04/13/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $33.79 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 105 | 160 | $23,965 | $6,654 |
| 2022 | 2 | 134 | 157 | $23,379 | $6,076 |
| 2021 | 3 | 211 | 395 | $53,992 | $20,058 |
| 2020 | 4 | 197 | 313 | $30,646 | $12,650 |
All Medicare Procedures & Services
11 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 64 | 95 | $11,875 | $3,352 | 28.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 41 | 65 | $12,090 | $3,302 | 27.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 82 | 104 | $13,332 | $3,474 | 26.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 52 | 53 | $10,047 | $2,603 | 25.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 90 | 159 | $25,895 | $9,342 | 36.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 105 | 215 | $23,859 | $8,843 | 37.1% |
| 99495 | Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge | Office | 2021 | 16 | 21 | $4,239 | $1,872 | 44.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 85 | 138 | $15,864 | $6,465 | 40.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 82 | 142 | $10,777 | $3,991 | 37.0% |
| 99495 | Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge | Office | 2020 | 19 | 22 | $3,565 | $1,885 | 52.9% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 11 | 11 | $440.00 | $308.46 | 70.1% |
About Roberta Korich, N.P
Roberta Korich, N.P is a Family healthcare provider based in Waterloo, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1053496315.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Roberta Korich, N.P has received a total of $3,092 in payments from pharmaceutical and medical device companies, with $12.91 received in 2023. These payments were reported across 178 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($3,092).
As a Medicare-enrolled provider, Korich has provided services to 647 Medicare beneficiaries, totaling 1,025 services with total Medicare billing of $45,438. Data is available for 4 years (2020–2023), covering 11 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Waterloo, NY
- Active Since 10/26/2006
- Last Updated 07/08/2007
- Taxonomy Code 363LF0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1053496315
Products in Payments
- UBRELVY (Drug) $395.05
- BREZTRI (Drug) $187.92
- FARXIGA (Drug) $185.70
- ELIQUIS (Drug) $157.35
- JARDIANCE (Drug) $156.25
- Ozempic (Drug) $154.77
- TRINTELLIX (Drug) $151.89
- STIOLTO RESPIMAT (Drug) $119.63
- TRELEGY ELLIPTA (Drug) $111.93
- NURTEC ODT (Drug) $109.90
- TRULICITY (Drug) $105.11
- QULIPTA (Drug) $94.12
- Vascepa (Drug) $80.76
- NUZYRA (Drug) $79.36
- EMGALITY (Drug) $73.95
- COLOGUARD DNA CAPTURE REAGENTS (Device) $68.10
- Aimovig (Biological) $66.50
- XARELTO (Drug) $63.37
- SHINGRIX (Biological) $59.45
- ANORO ELLIPTA (Drug) $53.84
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Waterloo
Mrs. Chi-Ying Sage, Arnp, ARNP
Family — Payments: $11,245
Michaela Johnson, Arnp, ARNP
Family — Payments: $7,312
Ute Gallert, Fnp, FNP
Family — Payments: $4,576
Megan O'neal, Arnp, ARNP
Family — Payments: $4,412
Sue Green, Fnp, FNP
Family — Payments: $2,483
Shanna Witges, Aprn Np-C, APRN NP-C
Family — Payments: $2,471